Amit Saxena

6.1k total citations · 1 hit paper
97 papers, 3.5k citations indexed

About

Amit Saxena is a scholar working on Rheumatology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Amit Saxena has authored 97 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Rheumatology, 22 papers in Cardiology and Cardiovascular Medicine and 21 papers in Immunology. Recurrent topics in Amit Saxena's work include Systemic Lupus Erythematosus Research (52 papers), Renal Diseases and Glomerulopathies (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Amit Saxena is often cited by papers focused on Systemic Lupus Erythematosus Research (52 papers), Renal Diseases and Glomerulopathies (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Amit Saxena collaborates with scholars based in United States, India and United Kingdom. Amit Saxena's co-authors include Nikolaos G. Frangogiannis, Peter Izmirly, Jill P. Buyon, Deborah Friedman, Ya Su, Mimi Kim, Ilaria Russo, Vikrant Rai, Ping Kong and Carolina Llanos and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Amit Saxena

87 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

2020 549 citations Brad H. Rovin, Y K Onno Teng et al. profile →

Peers

Countries citing papers authored by Amit Saxena

Since Specialization

Citations

This map shows the geographic impact of Amit Saxena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Saxena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Saxena more than expected).

Fields of papers citing papers by Amit Saxena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Saxena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Saxena. The network helps show where Amit Saxena may publish in the future.

Co-authorship network of co-authors of Amit Saxena

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Saxena. A scholar is included among the top collaborators of Amit Saxena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Saxena. Amit Saxena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases 2025 ·ACR Open Rheumatology ·Roberto Caricchio, Stacie Bell, Sasha Bernatsky, Maria Dall’Era, David H. Goddard, Kenneth Kalunian, Alfred H.J. Kim, Fotios Koumpouras, (unknown), Amit Saxena, Saira Z. Sheikh	0
2	Effect of Long‐Term Voclosporin Treatment on Renal Histology in Patients With Active Lupus Nephritis With Repeat Renal Biopsies 2025 ·Arthritis & Rheumatology ·Brad H. Rovin, Clarissa A. Cassol, Samir V. Parikh, Amit Saxena, Neil Solomons, (unknown), Ernie Yap, (unknown), David Jayne, Robert B. Huizinga	0
3	Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials 2025 ·Lupus Science & Medicine ·Amit Saxena, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jill P. Buyon	1
4	Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia 2024 ·ACR Open Rheumatology ·(unknown), Philip M. Carlucci, (unknown), Mala Masson, Amit Saxena, H. Michael Belmont, Chung‐E Tseng, Kamil E. Barbour, Heather T. Gold, Jill P. Buyon, Peter Izmirly	4
5	Safety and Efficacy of Long‐Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial 2023 ·Arthritis & Rheumatology ·Amit Saxena, Ellen M. Ginzler, Keisha L. Gibson, Bancha Satirapoj, (unknown), Olena Levchenko, Sandra Navarra, Tatsuya Atsumi, Shinsuke Yasuda, (unknown), Cristina Arriens, Samir V. Parikh, Dawn J. Caster, (unknown), Simrat Randhawa, Laura Lisk, Robert B. Huizinga, Y K Onno Teng	49
6	Vaccination updates and special considerations for systemic lupus erythematosus patients 2023 ·Current Opinion in Rheumatology ·(unknown), (unknown), Amit Saxena	1
7	Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay andCrithidia luciliaeassay in a multiethnic racial cohort of patients with SLE 2023 ·Lupus Science & Medicine ·(unknown), Amit Saxena, Peter Izmirly, Jill P. Buyon, H. Michael Belmont	3
8	1202 Voclosporin for Lupus Nephritis: Results of the Two-year AURORA 2 Continuation Study 2022 ·SHILAP Revista de lepidopterología ·Amit Saxena, (unknown), (unknown), (unknown), Henry Leher	3
9	Long-Term Use of Voclosporin in Patients With Class V Lupus Nephritis: Results From the AURORA 2 Continuation Study 2022 ·Journal of the American Society of Nephrology ·Dawn J. Caster, Amit Saxena, Salem Almaani, (unknown), Henry Leher	2
10	Tuberculous Osteomyelitis of Mandible: A Case Report 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Amit Saxena, (unknown), (unknown)	1
11	Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation 2020 ·Circulation Arrhythmia and Electrophysiology ·Deborah Friedman, Mimi Kim, N. Costedoat‐Chalumeau, Robert M. Clancy, Joshua A. Copel, Colin K. L. Phoon, Bettina F. Cuneo, (unknown), Mala Masson, (unknown), Noël Zahr, Amit Saxena, Peter Izmirly, Jill P. Buyon	20
12	Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers 2020 ·Journal of the American College of Cardiology ·Peter Izmirly, Mimi Kim, Deborah Friedman, N. Costedoat‐Chalumeau, Robert M. Clancy, Joshua A. Copel, Colin K. L. Phoon, Bettina F. Cuneo, (unknown), Kimberly Robins, Mala Masson, (unknown), Noël Zahr, Amit Saxena, Jill P. Buyon	101
13	Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study 2020 ·Arthritis Research & Therapy ·Ruth Fernandez‐Ruiz, Nicole Bornkamp, Mimi Kim, Anca Askanase, (unknown), (unknown), H. Michael Belmont, Amit Saxena, Jane E. Salmon, Michael D. Lockshin, Jill P. Buyon, Peter Izmirly	24
14	Autoimmune-mediated congenital heart block 2019 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·(unknown), (unknown), (unknown), (unknown), Amit Saxena, Jill P. Buyon, Peter Izmirly	43
15	3T chemical shift‐encoded MRI: Detection of altered proximal femur marrow adipose tissue composition in glucocorticoid users and validation with magnetic resonance spectroscopy 2018 ·Journal of Magnetic Resonance Imaging ·(unknown), Benjamin Leporq, Amit Saxena, H. Michael Belmont, (unknown), Stephen Honig, Ravinder R. Regatte, Gregory Chang	21
16	Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus 2015 ·Journal of the American College of Cardiology ·Amit Saxena, Peter Izmirly, Sung Won Han, Paraskevi Briassouli, Tania L. Rivera, Judy Zhong, Deborah Friedman, Robert M. Clancy, Jill P. Buyon	25
17	The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction 2015 ·Journal of Molecular and Cellular Cardiology ·Amit Saxena, Arti V. Shinde, (unknown), (unknown), Wei Chen, Ya Su, Nikolaos G. Frangogiannis	17
18	Prevention and Treatment In Utero of Autoimmune-Associated Congenital Heart Block 2014 ·Cardiology in Review ·Amit Saxena, Peter Izmirly, (unknown), Jill P. Buyon, Deborah Friedman	66
19	Neonatal lupus 2012 ·Current Opinion in Rheumatology ·Peter Izmirly, Jill P. Buyon, Amit Saxena	34
20	Pulmonary Artery Calcification in Recipient Twins of Twin to Twin Transfusion Syndrome: A Report of Three Cases 2003 ·Pediatric Cardiology ·Amit Saxena, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact